Daily Dose Pharmaceuticals Private Limited - Company Profile

It is a non-profit organizations private limited company based in Nashik, Maharashtra, India, established in 2017.
2017 Nashik, Maharashtra, India Active
Last Updated:
Access Report
About Daily Dose Pharmaceuticals Private Limited

Daily Dose Pharmaceuticals Private Limited, a active private limited company, was established on 02 March 2017 in Nashik, Maharashtra, India. Engaging in social work activities with accommodation within the non-profit organizations sector, it holds CIN: U85310MH2017PTC291901. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Suvarna Bhaskar Ingle (Director), Sonali Shekhar Ingle (Director), Nilesh Dashrath Baviskar (Director). Past directors included Suvarna Bhaskar Ingle, Mohsin Jafar Baig, Mahesh Madhavrao Sanap. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Pn 16, Sn 20/2, Aashish Vasanti Co Op Soci, Peth Road, Makhmalabad, Nashik, Maharashtra, 422003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85310MH2017PTC291901

  • Registration Number

    291901

  • Incorporation Date

    02 March 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.00 M
  • Revenue Growth **** 12.32%
  • Profit Growth **** 3.41%
  • Ebitda **** 8.41%
  • Net Worth 39.92%
  • Total Assets **** 20.67%
Company report

Daily Dose Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Daily Dose Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Daily Dose Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Suvarna Bhaskar Ingle Director 08 Mar 2017 Current
Sonali Shekhar Ingle Director 17 Jul 2018 Current
Nilesh Dashrath Baviskar Director 02 Mar 2017 Current
Shekhar Bhaskar Ingle Director 02 Mar 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 10 Aug 2018 Past
Pramod Abcsdd Additional Director 10 Aug 2018 Past
Pramod Abcsdd Director 18 Nov 2020 Past
Pramod Abcsdd Additional Director 04 Dec 2017 Past
Pramod Abcsdd Director 09 Dec 2019 Past
Pramod Abcsdd Additional Director 10 Aug 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Daily Dose Pharmaceuticals.

Daily Dose Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.32% increase. The company also saw a slight improvement in profitability, with a 3.41% increase in profit. The company's net worth Soared by an impressive increase of 39.92%.

Daily Dose Pharmaceuticals revenue growth over time
Daily Dose Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.32%
*******
*******
*******
*******
Revenue from Operations
*******
 12.34%
*******
*******
*******
*******
Total Assets
*******
 20.67%
*******
*******
*******
*******
Profit or Loss
*******
 3.41%
*******
*******
*******
*******
Net Worth
*******
 39.92%
*******
*******
*******
*******
EBITDA
*******
 8.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Daily Dose Pharmaceuticals?

Unlock access to Daily Dose Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
21 Jan 2025 Canara Bank ₹1.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Daily Dose Pharmaceuticals?

Unlock and access historical data on people associated with Daily Dose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Daily Dose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daily Dose Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Daily Dose Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Daily Dose Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Daily Dose Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 101033547 was registered on 21 Jan 2025. was completed.

  • Director Appointment

    The activity Sonali Shekhar Ingle was appointed as a Director was appointed as a Director on 17 Jul 2018 & has been associated with this company since 7 years 6 months . was completed.

  • Director Appointment

    Progress on Suvarna Bhaskar Ingle was appointed as a Director was appointed as a Director on 08 Mar 2017 & has been associated with this company since 8 years 10 months . was documented.

  • Director Appointment

    Progress on Nilesh Dashrath Baviskar was appointed as a Director was appointed as a Director on 02 Mar 2017 & has been associated with this company since 8 years 11 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Daily Dose Pharmaceuticals Private Limited?

The CIN of Daily Dose Pharmaceuticals Private Limited is U85310MH2017PTC291901.

Where is Daily Dose Pharmaceuticals Private Limited headquartered?

Daily Dose Pharmaceuticals Private Limited is headquartered at Pn 16, Sn 20/2, Aashish Vasanti Co Op Soci, Peth Road, Makhmalabad, Nashik, Maharashtra, 422003.

When was Daily Dose Pharmaceuticals Private Limited incorporated?

Daily Dose Pharmaceuticals Private Limited was incorporated on 02 March 2017.

Who are the current directors of Daily Dose Pharmaceuticals Private Limited?

The current directors of Daily Dose Pharmaceuticals Private Limited are

What is the primary industry of Daily Dose Pharmaceuticals Private Limited?

The primary industry of Daily Dose Pharmaceuticals Private Limited is Non-Profit Organizations.

Is Daily Dose Pharmaceuticals Private Limited a listed company?

Daily Dose Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Daily Dose Pharmaceuticals Private Limited?

The authorized capital of Daily Dose Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Daily Dose Pharmaceuticals Private Limited?

The compliance status of Daily Dose Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available